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Abstract
Cells alter the proteome to respond to environmental and developmental cues. Global analysis of 
proteomic responses is of limited value in heterogeneous environments, where there is no 
“average” cell. Advances in sequencing, protein labeling, mass spectrometry, and data analysis 
have fueled recent progress in the investigation of specific subpopulations of cells in complex 
systems. Here we highlight recently developed chemical tools that enable cell-selective proteomic 
analysis of complex biological systems, from bacterial pathogens to whole animals.
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Introduction
Cellular protein synthesis changes rapidly in response to internal and external cues in ways 
that vary from cell to cell. Global proteomic analyses of microbial communities, tissues and 
organisms have provided important insights into the behavior of such systems, but can 
obscure the diversity of responses characteristic of different cellular subpopulations (Figure 
1). Cell-selective methods for the analysis of protein synthesis are being developed to 
resolve proteomic changes in space and time.
Cell-type-specific transcriptomics experiments have revealed mRNA expression patterns in a 
wide array of biological systems, but mRNA and protein levels are often dissonant [1]. 
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Moreover, some important elements of proteome dynamics, including posttranslational 
modification, degradation, and localization, cannot be addressed by mRNA measurements 
alone [2,3]. Until recently, changes in protein abundance in specific cells could be measured 
only in targeted, low-throughput experiments, but innovations in mass spectrometry and 
computational algorithms have facilitated the identification and quantification of thousands 
of proteins simultaneously from complex biological samples [4–6].
In this Opinion, we highlight recent developments in determining cell-type-specific 
proteomes and recommend experimental design strategies that are guided by the question at 
hand.
Cell-selective translatomics and ribosome profiling
Translatomic studies, which select for ribosome-associated transcripts, have yielded stronger 
correlations between transcript and protein abundances than experiments that measure 
steady-state mRNA levels [7]. Cell-type-specific studies have been enabled by translating 
ribosome affinity purification (TRAP), a method in which epitope-tagged ribosomes and 
their associated transcripts are captured, enriched and subjected to amplification and deep 
sequencing [8]. TRAP can be rendered cell-specific by placing expression of the tagged 
ribosome under control of a selective promoter.
More recently, Ingolia and Weissman have developed ribosome profiling, which identifies 
ribosome-protected mRNA footprints and allows investigators to determine ribosome 
occupancy with positional specificity. This information can be used to measure translation 
levels and locate non-canonical start sites [7]. Gonzalez et al. used TRAP to cell-selectively 
purify ribosome-bound transcripts, and employed ribosome profiling to identify the 
translatome of gliomas and to reveal decreased translation in glial progenitors compared to 
the tumor microenvironment [9]. Ribosome profiling is a powerful technique that we expect 
to find increasing use upon further development of cell-specific methods.
While translatomic studies provide greater depth of coverage than current proteomic 
measurements, ribosome binding does not ensure that a transcript is undergoing active 
translation [10].
Separating cells for steady-state proteomic analysis
The earliest strategies to determine cell-specific proteomes relied on separating and 
purifying the cells of interest prior to analysis. Cells can be sorted on the basis of expression 
of a transgene under control of a cell-specific promoter or by antibody staining of marker 
epitopes. These tools are well established and have been thoughtfully reviewed [10,11]. 
Physical methods have been used for years to isolate cell types from mammalian tissues for 
subsequent downstream analyses [12,13]. More recently these methods have been used to 
measure growth rates and elucidate proteomic signatures of Salmonella during murine 
infection [14].
Physical separations remain the best method for analyzing clinical specimens and 
genetically intractable organisms. However, imperfect separations and long sample 
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processing times can diminish selectivity and increase the likelihood of artifacts. 
Furthermore, such methods intrinsically yield steady-state proteomic information. In 
contrast, metabolic labeling strategies enable cell-specific proteomic analysis to be 
accomplished in time-resolved fashion.
Metabolic labeling: trade-offs between sensitivity and perturbation
Metabolic labeling methods are temporally resolved and use an arsenal of amino acid 
isotopologs, non-canonical amino acids, and analogs of protein synthesis inhibitors (Figure 
2). Each of these strategies can be placed under control of cell-specific genetic elements to 
afford cellular resolution. The choice of promoter(s) is key for these systems, and the degree 
of protein labeling needs to be weighed against the possibility of perturbing the system. 
Results should be validated via independent assays because labels may affect protein 
expression, stability, and/or function.
Cell-type-specific labeling using amino acid precursors (CTAP)
Stable isotope labeling by amino acids in cell culture (SILAC) relies on the incorporation of 
isotopically labeled amino acids into proteins. To make SILAC cell-selective, Gauthier et al. 
introduced cell-type-specific labeling using amino acid precursors (CTAP), a method that 
exploits the fact that lysine is an essential amino acid in mammalian cells [15]. Cell-selective 
expression of biosynthetic enzymes allows L-lysine isotopologs to be synthesized in situ 
starting from isotope-labeled precursors. Only minor differences in gene expression resulted 
from feeding the heavy precursor to cells expressing the biosynthetic machinery versus 
supplementing cells directly with L-lysine.
In principle, both exchange of L-lysine between cells and extracellular processing of the 
precursor can compromise the cell-specificity of the CTAP method. When Lavis and 
coworkers employed an analogous strategy to unmask fluorophores in targeted cells, they 
noted that the unmasked small molecule diffused through gap junctions. This effect can be 
exploited to study cell-cell connectivity, but would confound cell-specific protein labeling if 
the small molecule were to diffuse to cells lacking the decaging enzyme [16]. To address 
these concerns, Tape et al. optimized CTAP for eukaryotic cell types and achieved ~90% 
cell-specific labeling in ten-day co-cultures [17]. Using their optimized method, Tape et al. 
combined CTAP with phosphoproteomics to study heterocellular KRASG12D signaling in 
pancreatic ductal adenocarcinoma cells [18]. By restricting their proteomic analysis to cells 
that expressed KRASG12D, the authors showed that the oncogene regulates AKT through 
reciprocal signaling – not through the accepted cell-autonomous pathway.
Bio-orthogonal Non Canonical Amino acid Tagging (BONCAT)
CTAP is most suitable for cell-specific experiments conducted in culture on timescales of 3–
7 days [19]. For studies that require better time resolution, the bio-orthogonal non-canonical 
amino acid tagging (BONCAT) method, introduced by Dieterich and coworkers, offers a 
good alternative [20,21]. In its original form, BONCAT exploits the capacity of the 
endogenous aminoacyl-tRNA synthetases to charge non-canonical amino acids (ncAAs) to 
their cognate tRNAs for incorporation into proteins. ncAAs bearing bio-orthogonal chemical 
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handles, often azides or alkynes, enable conjugation to affinity tags and separation of tagged 
proteins from the rest of the protein pool. The methionine surrogates azidohomoalanine 
(Aha) and homopropargylglycine (Hpg) have been used to probe proteome dynamics in 
bacterial [22–26] and mammalian [27] systems, and notably, to enrich and quantify secreted 
proteins [28]. Depletion of cellular methionine is not necessary for Aha labeling; Bagert et 
al. showed that a 30:1 ratio of Aha to Met yielded excellent protein labeling while 
minimizing perturbations that might be expected to arise from methionine starvation [29]. 
Other studies have shown that ncAA labeling for periods of up to two days do not perturb 
embryonic growth in live mice [30]. In designing a BONCAT experiment, the investigator 
should choose concentrations of the ncAA label and its natural counterpart that reflect the 
relative rates of activation of the amino acids by the cognate synthetase.
In 2009, Ngo and coworkers developed a cell-selective version of BONCAT by engineering 
an E. coli methionyl-tRNA synthetase (EcMetRS) variant that activates azidonorleucine 
(Anl). Because Anl is a poor substrate for wild-type EcMetRS, labeling is essentially 
restricted to cells that express the mutant synthetase. In the first example of the cell-specific 
BONCAT method, Ngo et al. reported specific labeling of E. coli cells co-cultured with 
murine alveolar macrophages [31]. Grammel et al. expanded on this method by enriching for 
proteins synthesized during Salmonella typhimurium infection [32], and Mahdavi and 
coworkers used BONCAT to determine the order in which Yersinia enterocolitica effector 
proteins are injected into HeLa cells in the course of infection [33].
Cell-selective BONCAT has now been extended to proteomic analysis in live animals, 
highlighting its potential utility in creating cell-specific proteomic “atlases”. In 2015 we 
reported a mutant phenylalanyl-tRNA synthetase (PheRS) that enables the use of p-
azidophenylalanine (Azf) as a BONCAT probe in Caenorhabditis elegans [34]. Combining 
cell-selective BONCAT with stable isotope labeling, we used the myo-2 promoter to direct 
expression of the mutant synthetase to the 20 pharyngeal muscle cells of the worm. We were 
able to quantify 2270 proteins by this method, and to verify the pharyngeal expression 
patterns of several previously uncharacterized proteins.
Dieterich and coworkers have adapted cell-selective BONCAT labeling to Drosophila 
melanogaster through controlled expression of the DmMetRS L262G mutant [35]. Chronic 
administration of Anl in developing flies expressing the mutant synthetase caused slight 
impairments in larval growth and behavior, but shorter (48 h) labeling times led to no 
noticeable defects. Importantly, administration of the amino acid in flies that did not express 
the mutant MetRS caused no discernible effect. Using this strategy, Niehues et al. measured 
reduced neuronal protein synthesis rates in a Drosophila model of Charcot-Marie-Tooth 
(CMT) neuropathy. Mahdavi et al. and Muller et al. have employed the analogous (L274G) 
mouse synthetase in mammalian cell culture and in a neuronglia co-culture system, 
respectively [36,37]. The latter experiments enabled the investigators to monitor changes in 
the astrocytic proteome in response to treatment with brain-derived neurotrophic factor 
(BDNF).
Split synthetases have been developed to enable cell-selective analysis of systems in which 
no single promoter restricts expression of the mutant enzyme to the cells of interest [38]. 
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Notably, all amino acids and enrichment media needed for BONCAT experiments are 
commercially available.
Stochastic Orthogonal Recoding of Translation (SORT)
Chin and coworkers have developed a residue-specific ncAA-labeling technology termed 
stochastic orthogonal recoding of translation (SORT), which – like BONCAT – allows 
chemoselective modification and enrichment of newly synthesized cellular proteins. SORT 
relies on expression of a pyrrolysyl-tRNA synthetase and its cognate tRNA [39,40]. Using 
this method, Elliott et al. cell-selectively labeled and identified proteins made during 
different stages of larval growth in Drosophila. Importantly, SORT allows the anticodon of 
the cognate tRNA to be changed to direct the ncAA to different sets of codons in the labeled 
proteins. Elliott et al. have characterized the enrichment process and found that tagging at 
different codons leads to the enrichment of overlapping, but distinct sets of proteins [41]. 
The authors noted that simultaneous expression of multiple tRNAs (i.e., tRNA-Ala, -Ser and 
-Met) increases labeling efficiency. Furthermore, Elliott et al. found that enrichment after 
tagging improves detection of low-abundance proteins.
Cell-selective O-propargyl-puromycin (OP-Puro) labeling
The O-propargyl-puromycin (OP-Puro) method also incorporates “clickable” handles into 
nascent proteins [42]. Cohen and coworkers recently achieved cell-targeted OP-puromycin 
labeling by using a phenylacetyl-caged analog that is uncaged by cell-selective expression of 
penicillin G acylase (PGA) [43]. The OP-puro method is the fastest of the metabolic labeling 
methods and the best suited for studies requiring ultra-short labeling times [44]. Prolonged 
labeling with OP-puro would be expected to perturb cellular behavior through inhibition of 
global translation. Furthermore, premature truncation renders this method ineffective for the 
identification of secreted proteins.
Spatially restricted & subcellular proteomics
Ting and coworkers first used a mutant ascorbate peroxidase (APEX) to selectively tag 
proteins localized to the mitochondrial matrix [45,46]. Unlike the cell-selective metabolic 
labeling methods just described, this method labels all proteins, including pre-existing 
proteins, within a subcellular volume. Chen et al. used this elegant strategy to characterize 
multiple cell types in Drosophila, including the mitochondrial matrix of muscle tissue [47]. 
The Weissman laboratory has combined the APEX labeling method with ribosome profiling 
to characterize localized protein synthesis in yeast [48,49]; extension of their method to cell-
selective analysis is readily imagined.
Choosing a cell-selective proteomic method
The choice of a cell-selective method of proteomic analysis should reflect careful 
consideration of the advantages and disadvantages of each of the available approaches 
(Table 1).
Physical sorting methods allow straightforward characterization of the steady-state proteome 
of the cell type of interest. However, removing cells from their natural environments prior to 
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analysis raises concerns about artifacts, leads to limited temporal information, and sacrifices 
information about secreted proteins.
Ribosome profiling, when combined with cell-selective TRAP, provides significantly higher 
coverage of the gene expression profile than any direct proteomic measurement. But 
ribosome profiling is not a perfect proxy for protein synthesis and yields no information 
regarding protein secretion [50]. Moreover, only direct proteomic methods allow detection 
of post-translational modifications.
CTAP simplifies quantitative proteomic measurements for samples of relatively low 
complexity, but enrichment-based strategies (i.e., BONCAT, SORT or OP-Puro) are likely to 
be superior for short labeling times or for analysis of rare cells in complex tissues. Only 
APEX yields snapshots of the steady-state proteome with sub-cellular resolution. All cell-
selective, enrichment-based experiments require the use of genetically tractable organisms.
Optimization of enrichment-based strategies requires careful consideration of alternative 
purification chemistries. Attachment to the resin used for purification can be accomplished 
either by direct covalent ligation or by a two-step process of affinity-tagging (e.g., with 
biotin reagents) and non-covalent binding (e.g., to streptavidin resins). Following 
appropriate washing steps, samples can be released from the resin by competitive binding, 
by proteolysis, or by selective cleavage of the affinity reagent. APEX appends biotin to 
surrounding molecules, so streptavidin-based resins are used to enrich for labeled proteins 
[46]. OP-Puro requires an azide-based affinity handle or resin for enrichment [43]. SORT 
uses cyclopropene labels and tetrazine linkers in a ligation reaction reported to be 100 to 
1000 times faster than the strain-promoted azide-alkyne cycloaddition [41]. BONCAT labels 
with either alkynes or azides, and enriches with complementary azide or alkyne reagents. A 
special consideration arises in the analysis of lysates labeled with azides: Free thiols, which 
are known to react with cyclooctynes, must be blocked with capping reagents such as 
iodoacetamide or N-ethylmaleimide to avoid high background [34]. Many azide and alkyne 
resins and linkers are commercially available, and tetrazine-based reagents are beginning to 
appear on the market.
If the investigator wishes to identify the sites at which protein labeling has occurred, linkers 
with cleavable moieties can be used [51]. For many experiments, though, identification of 
labeling sites is not necessary, and on-bead digestion of enriched proteins is often simpler 
and more straightforward. In our hands, directly conjugating azide-labeled lysates to 
cyclooctyne resins has allowed us to identify larger numbers of relevant proteins [34]. 
Because enrichments are never perfect, running mock enrichments of unlabeled sample 
along with labeled samples provides a useful indication of background reactivity and non-
specific protein contamination. Samples with abundant contaminating biopolymers such as 
pectin, serum proteins, or mucin may need an additional step to remove or degrade these 
contaminants and facilitate successful enrichment.
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Conclusions and future outlook
Recent years have witnessed the introduction of powerful techniques that allow investigators 
to monitor protein synthesis with unprecedented resolution in space and time. Cell-specific 
proteomic analyses will play a key role in the identification of the mechanisms that govern 
cell specialization and that allow complex organisms to respond to changing environments.
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Highlights
• Cell-selective proteomics is important in complex, heterocellular 
environments
• Innovative chemical tools enable unbiased cell-type-specific interrogation of 
translation
• Labeling methods including TRAP, CTAP, BONCAT, SORT, OP-Puro and 
APEX have been developed for cell-selective analysis
• Sequencing and mass spectrometry-based strategies complement one other in 
the study of protein synthesis
• The strengths and limitations of each analytical method must be considered 
carefully in the context of the biological question to be addressed
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Figure 1. 
The importance of cell-type-specific proteomics. Bulk measurements of complex tissues can 
obscure proteomic changes that occur in specific sub-populations of cells. A protein that is 
highly expressed (up arrows) in the cells of interest might be detected at low abundance 
overall due to low expression (down arrows) in background cells. Cells of interest must be 
physically isolated or tagged to measure the cell-specific proteome. Physical isolation 
measures steady-state levels of intracellular proteins, whereas labeling methods can be time-
resolved and used to identify secreted proteins.
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Figure 2. 
Labeling strategies for cell-selective proteomics. a) The process by which amino acids are 
incorporated into proteins, and the step exploited by each of the labeling methods discussed 
in this Opinion. b) Schematic of each technique.
Translating ribosome affinity purification: TRAP; Cell type-specific labeling using amino 
acid precursors: CTAP; Bio-orthogonal non-canonical amino acid tagging: BONCAT; 
Stochastic orthogonal recoding of translation: SORT; O-propargyl puromycin: OP-Puro; 
ascorbate peroxidase: APEX; Lysine racemase:Lyr; diaminopimelate decarboxylase: DDC; 
aminoacyl-tRNA synthetase: RS; penicillin-G-acylase: PGA.
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